Beta-amyloid protein production. secretion inhibitor
申请人:Yasukouchi Takanori
公开号:US20050234109A1
公开(公告)日:2005-10-20
Provided are novel compounds having an inhibitory activity against production or secretion of β-amyloid protein. They embrace compounds represented by the following formula (1):
and capable of being replaced with a variety of substituents; and salts thereof, and solvates of any one of them.
Provided is a compound capable of inhibiting production or secretion of β amyloid protein.
A compound represented by the following formula (1):
(wherein, R
1
represents a heterocyclic group which may have a substituent, R
2
represents a cyclic hydrocarbon group which may have a substituent or a heterocyclic group which may have a substituent, R
3
represents a cyclic hydrocarbon group which may have a substituent or a heterocyclic group which may have a substituent, R
4
represents a hydrogen atom or a C
1-6
alkyl group, and X represents —S—, —SO— or —SO
2
—); an N-oxide or S-oxide thereof; a salt thereof; or a solvate thereof; and a medicament containing any of them.
BETA-AMYLOID PROTEIN PRODUCTION/SECRETION INHIBITORS
申请人:YASUKOUCHI Takanori
公开号:US20070293495A1
公开(公告)日:2007-12-20
Provided are novel compounds having an inhibitory activity against production or secretion of β-amyloid protein. They embrace compounds represented by the following formula (1):
and capable of being replaced with a variety of substituents; and salts thereof, and solvates of any one of them.
Provided are novel compounds having an inhibitory activity against production or secretion of β-amyloid protein. They embrace compounds represented by the following formula (1):
and capable of being replaced with a variety of substituents; and salts thereof, and solvates of any one of them.
Provided is a compound capable of inhibiting production or secretion of β amyloid protein.
A compound represented by the following formula (1):
(wherein, R1 represents a heterocyclic group which may have a substituent, R2 represents a cyclic hydrocarbon group which may have a substituent or a heterocyclic group which may have a substituent, R3 represents a cyclic hydrocarbon group which may have a substituent or a heterocyclic group which may have a substituent, R4 represents a hydrogen atom or a C1-6 alkyl group, and X represents —S—, —SO— or —SO2—); an N-oxide or S-oxide thereof; a salt thereof; or a solvate thereof; and a medicament containing any of them.